EW vs T · P/E 47, rev $1.39B vs P/E 7.4, rev $125.65B
Edwards Lifesciences Corp (EW) versus AT&T Inc. (T) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
AT&T Inc. (T) is a telecom services company listed on NYSE. It is led by John Stankey.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported T revenue for 2025-12-31 was $125.65B. Net income was $21.95B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. T currently screens at market cap $155.92B and trailing P/E 7.4.
EW currently screens at market cap $49.91B and trailing P/E 46.9. T currently screens at market cap $155.92B and trailing P/E 7.4.
Not investment advice. Open the EW and T stock pages for the full models.
Not investment advice.